Roche files Avastin in US for lung cancer treatment
Avastin, the most promising new cancer drug of the past 10 years, on Wednesday passed another milestone with a request in the US for regulatory approval for advanced lung cancer.
The product, an injectable drug discovered by Genentech and marketed by Roche, has gone on sale in 77 countries in its initial indication for advanced colorectal cancer. A request for regulatory approval for a third indication, advanced breast cancer, is expected shortly, confirming Avastin's unusual potential as a treatment for varying forms of solid tumours, compared with the more focused nature of most cancer drugs targeted at single forms
· Read The Full Lung Cancer Article From MSNBC -->
·
Read All Lung Cancer News Stories -->